Asymptomatic testing is suggested for transplant donors/recipients, inpatients being discharged to nursing homes, and hematology-oncology patients prior to administration of severely immunosuppressive anti-neoplastic chemotherapy.
Asymptomatic testing is suggested for transplant donors/recipients, inpatients being discharged to nursing homes, and hematology-oncology patients prior to administration of severely immunosuppressive anti-neoplastic chemotherapy.